Gene therapy developer bluebird bio to cut 30% of staff

The company said Tuesday morning that the layoffs are part of a restructuring intended to save as much as $160 million over the next two years.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.